Troglitazone

This classification denotes a differentiation inducer and anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) I66ZZ0ZN0E. European Medicines Agency schedules Troglitazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11332MIG. Troglitazone generally arises in the molecular formula C24H27NO5S. The term TROGLITAZONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 7, no3, 1993, list 33.) TROGLITAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule troglitazone under HS 29341000 and SITC 51579. As of Q4 2014, TROGLITAZONE remains US FDA's Preferred Term for this commodity. Troglitazone bears US NLM identifiers UMLS ID C0245514 and NCI Concept Code C1522. SMILES: CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O.